For The Better

Medtronic grew revenue by 14% in the first quarter of its fiscal 2027.

What does a sevenfold sales leap for a Chinese rival say about the memory maker’s stock?

Saylor sees one price dynamic as being particularly important to differentiating between bull and bear regimes.

Valuations are improving as earnings are growing faster than prices.

Bloom Energy is growing into its valuation, and the most recent quarter marks an important turning point.

Azure grew faster than management’s own forecast. Is that enough to make the stock a buy around $530?

J.P. Morgan sees the coin as a better performer than stocks, though it comes at a cost.

The Buffett premium may not have been as significant as investors thought; diversification and cash may be more important.

What comes next for this data analytics giant?

In 2022, the energy sector rocketed higher even as the S&P 500 index plunged.

These two companies could move in different directions over the medium term.

Eli Lilly stock is trading at a record high.

The e-commerce company has beaten its own forecast all year. Is a cheaper stock enough to buy ahead of the next one?

These companies could perform well whether or not they announce stock splits.

IEMG charges just 0.09% annually versus EEM’s 0.72%, and holds nearly 2,900 stocks for broader diversification. Both track similar sectors but deliver different risk-return profiles.

Boeing’s production and cash flow targets have been delayed, disappointing investors, but the updated targets may prove conservative.

Capital outlays of this magnitude require investors to keep a closer eye on the company’s progress.

One prioritizes high current payouts with lower costs; the other emphasizes over 25 years of dividend growth. We break down the risk-adjusted returns and sector tilts.

The IPO is expected soon, and it could be the biggest ever. Here’s what you need to know.

Anthropic recently dropped its long-awaited S-1 filing.